Dr. Leonard, who has worked at Intellia since 2014, currently serves as the company’s executive vice president of research and development. He previously served as Intellia’s CMO.
Dr. Leonard came to Intellia from AbbVie, a global biopharmaceutical company, where he was chief scientific officer and senior vice president of research and development.
Dr. Leonard succeeds Nessan Bermingham, PhD, Intellia’s founding president and CEO, who is leaving for the venture capital arena.
More articles on health IT:
FCC approves measure to dismantle net neutrality in 3-2 vote
FTC issues privacy warning over direct-to-consumer genetic tests
Allscripts CEO Paul Black talks McKesson acquisition, 2018 goals: 6 questions
